Family members of President Donald Trump and Commerce Secretary Howard Lutnick are set to profit from the U.S. government's pharma overhaul. Read more here.
Trump is studying a drug sales reform that would favor a company linked to his first-born son, according to the newspaper 'The Wall Street Journal'. The country's leading drug manufacturers will meet in early December at the Four Seasons Hotel in Georgetown with Donald Trump Jr. and senior officials of the Trump Administration who regulate the pharmaceutical industry, reports the U.S. newspaper.Continue reading....